neurizon ApS: Financial statements 2018
CVR: 36889845
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
neurizon ApS (CVR 36889845) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -6,200 and a net result of DKK -10,108 compared with DKK -3,326 the year before. Equity in the 2018 report amounted to DKK 34,026. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK -6,200
- Profit/Loss
- DKK -10,108
- Equity
- DKK 34,026
- Total Assets
- DKK 34,026
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 0 | -6 t. | -10 t. | 34 t. | - |
| 2017 | - | 562 | -3 t. | 30 t. | - |
| 2016 | - | -13 t. | -17 t. | 34 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Neurizon ApS has published its annual report for 2017. Gross profit came to DKK 562, and the net result was DKK -3,326.
About neurizon ApS
neurizon ApS is a Danish company of the type Anpartsselskab based in Egå, founded in 2015. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Kaare Stenhøj Meier. The board consists of Jens Christian Hedemann Sørensen (chair), Kaare Stenhøj Meier, Mattias karl Johan Valdemar Rasmusson and Morten Flink. The company's owners include ITMEDICO HOLDING ApS, KYNOS ApS and Neurologic Holding ApS. In 2025, the company reported a gross profit of DKK 4,175 and a net result of DKK 1,642 compared with DKK -585 the year before. Equity in the 2025 report amounted to DKK 92,461.
